Manufacturer record
WINGS BIOTECH LLP: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
16 batches manufactured by WINGS BIOTECH LLP (Himachal Pradesh) were declared Not of Standard Quality between June 2024 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
16 records linked to WINGS BIOTECH LLP in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ibuprofen Tablets I.P. 400 mg | IBPT-1003Mfg 2024-07 · Exp 2027-06 | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution of Ibuprofen.Dissolution | RDTL, GuwahatiCDSCO lab | Jul 2026 |
| Ibuprofen Tablets IP 400 mg | IBPT-1002Mfg 2024-07 · Exp 2027-06 | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, GuwahatiState lab | Jun 2026 |
| Rosuvastatin Tablets IP 20 mg | RVST-1040Mfg 2025-11 · Exp 2027-10 | The sample does not conform to I.P with respect to the test for Related substancesRelated substances | CDL, KolkataCDSCO lab | May 2026 |
| Ondansetron Tablets IP | ONST-1006Mfg 2026-07 · Exp 2027-06 | The sample does not conform to claim as per IP 2022 and Addendum 2024 in respect to the test of Dissolution.Dissolution | RDTL, ChandigarhCDSCO lab | May 2026 |
| Glimepiride, Pioglitazone Hydrochloride and Metformin Hydrochloride Sustained-release Tablets (2mg/15mg/500mg) | GMPT-1050Mfg 2024-01 · Exp 2025-12 | Assay for Glimepiride" onlyAssay | RDTL, Hubli, KarnatakaState lab | Nov 2025 |
| Lindane Lotion USP 1% | LNE-1020Mfg 2025-08 · Exp 2027-07 | The above product is official in IP 2022 (Addendum 2024 W.e.f july 2024) but it is claimed as USP as on Manufacturing date.Other | SDTL, PunjabState lab | Oct 2025 |
| Telmisartan and Hydrochlorothizide Tablets I.P (40mg/12.5mg) | TMHT-1037Mfg 2023-10 · Exp 2026-09 | Uniformity of WeightUniformity of weight/content | State Lab KarnatakaState lab | Jun 2025 |
| Telmisartan and Hydrochlorothiazide Tablets I.P (40mg/12.5 mg) | TMHT-1012Mfg 2023-09 · Exp 2026-08 | Uniformity of weightUniformity of weight/content | State Lab KarnatakaState lab | Jun 2025 |
| Telmisartan and Hydrochlorothiazide Tablets I.P. (40mg/12.5mg) | TMHT1046Mfg 2023-10 · Exp 2026-09 | Uniformity of WeightUniformity of weight/content | State Lab KarnatakaState lab | Jun 2025 |
| Norfloxacin Tablets I.P. 400mg. | NFXT-1002Mfg 2023-06 · Exp 2026-05 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Feb 2025 |
| DICLOFENAC SODIUM AND PARACETAMOL TABLETS I.P (DiCLOWiN PLUS) | DPT- 5765Mfg ? · Exp ? | Does not comply with respect to Assay for Diclofenac sodium -NSQAssay | PuducherryState lab | Feb 2025 |
| Paracetamo l, Cetirizine Hydrochlori de & Phenylephri ne Hydrochlori de Tablets (WINCOLD Z) | WNZT- 3240Mfg 2023-11 · Exp 2026-10 | On the received sample presence of spots were observed which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discoloration - NSQDescription | State Lab PuducherryState lab | Jan 2025 |
| Aceclofast | 60Mfg 2023-11 · Exp 2025-10 | Sample does not conform to Label claim with respect to the content of Aceclofenac and it contains DiclofenacDiethylamine which is not declared on the label.Labelling | DTL ChennaiState lab | Nov 2024 |
| Montelukast Sodium and Levocetirizine Hydrochloride Tablets IP 10 mg/5 mg | MLHT-1022Mfg 2023-09 · Exp 2026-08 | It fails the test ?Dissolution? Specified in the Laboratory Protocol as per IPDissolution | DTL ThiruvananthapuramState lab | Oct 2024 |
| Ciprofloxacin Hydrochloride Tablets IP 500 mg | CPXT-1016Mfg 2023-10 · Exp 2026-09 | It fails the test ?Dissolution? as per IPDissolution | DTL ThiruvananthapuramState lab | Jul 2024 |
| Prednisolone Tablets IP 10 mg | PRDT- 1007Mfg 2024-11 · Exp 2024-10 | Assay of PrednisoloneAssay | RDTL ChandigarhCDSCO lab | Jun 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.